CENTENE CORP
About CENTENE CORP
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $174.6B
- Net income
- -$6.7B
- Total assets
- $76.7B
- Market cap
- $30.8B
- Gross margin
- 7.3%
- Operating margin
- -3.9%
- Net margin
- -3.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $194.8B
- Cost of revenue
- $2.7B
- Gross profit
- $14.2B
- Operating expenses
- $21.8B
- Operating income
- -$7.6B
- Income tax
- -$51.0M
- Net income
- -$6.7B
- EPS (basic)
- $-13.53
- EPS (diluted)
- $-13.53
Balance sheet
- Total assets
- $76.7B
- Current assets
- $40.4B
- Total liabilities
- $56.7B
- Current liabilities
- $36.7B
- Shareholders’ equity
- $20.0B
Cash flow
- Operating cash flow
- $5.1B
- Investing cash flow
- $472.0M
- Financing cash flow
- -$1.6B
- Net cash flow
- $3.9B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $30.8B
- EPS (diluted)
- $-13.53
- Shares outstanding
- 473.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 13, 2001
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $6.7B in FY2025.
- Revenue grew 55% from FY2021 to FY2025.
- Gross margin of 7.3%, net margin -3.4%.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CENTENE CORP.
Write a review
News about CENTENE CORP
News & sentiment via Polygon.io